Koyfin Home > Directory > Health Care > Acorda Therapeutics > Price / Sales (ntm)

Acorda Therapeutics Price / Sales (ntm) Chart (ACOR)

Acorda Therapeutics annual/quarterly Price / Sales (ntm) from 2010 to 2020.
  • Acorda Therapeutics Price / Sales (ntm) for the quarter ending September 09, 2020 was 0.26 a -9.67% decrease of -0.02 year over year
  • Acorda Therapeutics Price / Sales (ntm) for the last 12 months ending September 09, 2020 was 0.26 a -9.67% decrease of -0.02 year over year
  • Acorda Therapeutics Annual Price / Sales (ntm) for 2020 was 0.26 a 2.17% increase of 0.01 from 2019
  • Acorda Therapeutics Annual Price / Sales (ntm) for 2020 was 0.25 a -4.33% decrease of -0.01 from 2019
  • Acorda Therapeutics Annual Price / Sales (ntm) for 2020 was 0.26 a -7.46% decrease of -0.02 from 2019
Other Valuation Metrics:
  • Acorda Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,110m a 17.15% increase of 190m year over year
  • Acorda Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.11 a 35.48% increase of 0.75 year over year
  • Acorda Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $1,138m a 2.19% increase of 25m year over year
View Chart On Koyfin

Quarterly ACOR Price / Sales (ntm) Data

09/20200.26
09/20200.25
09/20200.26
09/20200.28
09/20200.27
09/20200.25
09/20200.22
09/20200.22
09/20200.23
09/20200.22

Annual ACOR Price / Sales (ntm) Data

20200.26
20200.25
20200.26
20200.28
20200.27
20200.25
20200.22
20200.22
20200.23
20200.22